Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children

Intensive Care Medicine

Volumn 33, Issue 7, 2007, Pages 1173-1178

  Shankar, Venkat ^a   Haque, Anwarul ^a   Churchwell, Kevin B ^a   Russell, William ^b  

^a Division of General Pediatrics   (United States)

^b MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

Author keywords

Diabetes mellitus; Diabetic ketoacidosis; Insulin; Pediatric

Indexed keywords

INSULIN; INSULIN GLARGINE;

ACIDOSIS; ARTICLE; CHILD; DIABETIC KETOACIDOSIS; DISEASE SEVERITY; DRUG INFUSION; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PH MEASUREMENT; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; COHORT STUDIES; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34447134305     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0674-3     Document Type: Article

References (17)

1. Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, Glaser NS, Hanas R, Hintz RL, Levitsky LL, Savage MO, Tasker RC, Wolfsdorf JI (2004) ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 89:188-194
2. Komulainen J, Lounamaa R, Knip M, Kaprio EA, Akerblom HK (1996) Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group. Arch Dis Child 75:410-415
3. Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M, Hamman RF, Klingensmith G (2002) Predictors of acute complications in children with type 1 diabetes. JAMA 287:2511-2518
4. Rosilio M, Cotton JB, Wieliczko MC, Gendrault B, Carel JC, Couvaras O, Ser N, Bougneres PF, Gillet P, Soskin S, Garandeau P, Stuckens C, Le luyer B, Jos J, Bony-Trifunovic H, Bertrand AM, Leturcq F, Lafuma A (1998) Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group. Diabetes Care 21:1146-1153
5. Smith CP, Firth D, Bennett S, Howard C, Chisholm P (1998) Ketoacidosis occurring in newly diagnosed and established diabetic children.Acta Paediatr 87:537-541
6. Levy-Marchal C, Papoz L, de Beaufort C, Doutreix J, Froment V, Voirin J, Czernichow P (1992) Clinical and laboratory features of type 1 diabetic children at the time of diagnosis. Diabet Med 9:279-284
7. Curtis JR, To T, Muirhead S, Cummings E, Daneman D (2002) Recent trends in hospitalization for diabetic ketoacidosis in ontario children. Diabetes Care 25:1591-1596
8. Hirasing RA, Reeser HM, de Groot RR, Ruwaard D, van Buuren S, Verloove-Vanhorick SP (1996) Trends in hospital admissions among children aged 0-19 years with type I diabetes in The Netherlands. Diabetes Care 19:431-434
9. Maldonado MR, Chong ER, Oehl MA, Balasubramanyam A (2003) Economic impact of diabetic ketoacidosis in a multiethnic indigent population: analysis of costs based on the precipitating cause. Diabetes Care 26:1265-1269
10. Monroe KW, King W, Atchison JA (1997) Use of PRISM scores in triage of pediatric patients with diabetic ketoacidosis. Am J Manag Care 3:253-258
11. Wagner A, Risse A, Brill HL, Wienhausen-Wilke V, Rottmann M, Sondern K, Angelkort B (1999) Therapy of severe diabetic ketoacidosis. Zero-mortality under very-low-dose insulin application. Diabetes Care 22:674-677
12. McKeage K, Goa KL (2001) Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus. Drugs 61:1599-1624
13. Dunn CJ, Plosker GL, Keating GM, McKeage K, Scott LJ (2003) Insulin glargine: an updated review of its use in the management of diabetes mellitus. Drugs 63:1743-1778
14. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM (2003) Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care 26(1):S109-S117
15. Grimberg A, Cerri RW, Satin-Smith M, Cohen P (1999) The "two bag system" for variable intravenous dextrose and fluid administration: benefits in diabetic ketoacidosis management. J Pediatr 134:376-378
16. Edge JA, Hawkins MM, Winter DL, Dunger DB (2001) The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child 85:16-22
17. Glaser N, Barnett P, McCaslin I, Nelson D, Trainor J, Louie J, Kaufman F, Quayle K, Roback M, Malley R, Kuppermann N (2001) Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med 344:264-269